These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 23747660)

  • 1. Multilayer laminar co-extrudate as a novel controlled release dosage form.
    Müllers KC; Wahl MA; Pinto JF
    Eur J Pharm Sci; 2013 Jul; 49(4):491-8. PubMed ID: 23747660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of dosage forms for oral drug delivery by laminar extrusion of wet masses.
    Müllers KC; Wahl MA; Pinto JF
    Eur J Pharm Biopharm; 2013 Aug; 84(3):626-32. PubMed ID: 23403012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivery of drugs from laminar co-extrudates manufactured by a solvent-free process at room temperature.
    Oliveira G; Wahl MA; Pinto JF
    J Pharm Sci; 2014 Nov; 103(11):3501-3510. PubMed ID: 25212969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled drug release from pellets containing water-insoluble drugs dissolved in a self-emulsifying system.
    Serratoni M; Newton M; Booth S; Clarke A
    Eur J Pharm Biopharm; 2007 Jan; 65(1):94-8. PubMed ID: 17056237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of laminar extrudates manufactured at room temperature in the absence of solvents for the delivery of drugs.
    Oliveira G; Wahl MA; Pinto JF
    Int J Pharm; 2013 Sep; 454(1):90-8. PubMed ID: 23845856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC.
    Sankalia JM; Sankalia MG; Mashru RC
    J Control Release; 2008 Jul; 129(1):49-58. PubMed ID: 18456362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of sustained-matrix tablets Ambroxol hydrochloride and potential impact of different fillers on the matrix tablet's scale-up].
    Wang MY; Yang YP; Chang JB; Guo MT
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Oct; 44(5):742-8. PubMed ID: 23073585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of polymer content on early gel-layer formation in HPMC matrices: The use of CLSM visualisation to identify the percolation threshold.
    Mason LM; Campiñez MD; Pygall SR; Burley JC; Gupta P; Storey DE; Caraballo I; Melia CD
    Eur J Pharm Biopharm; 2015 Aug; 94():485-92. PubMed ID: 26143369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of excipients on drug release from hydroxypropyl methylcellulose matrices.
    Levina M; Rajabi-Siahboomi AR
    J Pharm Sci; 2004 Nov; 93(11):2746-54. PubMed ID: 15389670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a HPMC-based controlled release formulation with hot melt extrusion (HME).
    Ma D; Djemai A; Gendron CM; Xi H; Smith M; Kogan J; Li L
    Drug Dev Ind Pharm; 2013 Jul; 39(7):1070-83. PubMed ID: 22803806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and evaluation of an ispaghula based directly compressible matrixing agent for controlled release.
    Lalwani AN; Parikh JR
    Acta Pharm; 2008 Sep; 58(3):309-16. PubMed ID: 19103567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel approach to sustained pseudoephedrine release: differentially coated mini-tablets in HPMC capsules.
    Ishida M; Abe K; Hashizume M; Kawamura M
    Int J Pharm; 2008 Jul; 359(1-2):46-52. PubMed ID: 18467046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and optimization of a novel sustained-release dextran tablet formulation for propranolol hydrochloride.
    Gil EC; Colarte AI; Bataille B; Pedraz JL; Rodríguez F; Heinämäki J
    Int J Pharm; 2006 Jul; 317(1):32-9. PubMed ID: 16584856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards functional characterization of excipients for oral solid dosage forms using UV-vis imaging. Liberation, release and dissolution.
    Li Z; Sun Y; Bar-Shalom D; Mu H; Larsen SW; Jensen H; Østergaard J
    J Pharm Biomed Anal; 2021 Feb; 194():113789. PubMed ID: 33298380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereoselective dissolution of propranolol hydrochloride from hydroxypropyl methylcellulose matrices.
    Duddu SP; Vakilynejad M; Jamali F; Grant DJ
    Pharm Res; 1993 Nov; 10(11):1648-53. PubMed ID: 8290480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of hydroxypropyl methylcellulose matrix systems as swellable gastro-retentive drug delivery systems (GRDDS).
    Matharu AS; Motto MG; Patel MR; Simonelli AP; Dave RH
    J Pharm Sci; 2011 Jan; 100(1):150-63. PubMed ID: 20572054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of various surfactants and their concentration on controlled release of captopril from polymeric matrices.
    Nokhodchi A; Hassan-Zadeh D; Monajjem-Zadeh F; Taghi-Zadeh N
    Acta Pharm; 2008 Jun; 58(2):151-62. PubMed ID: 18515225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced formulation design of venlafaxine hydrochloride coated and triple-layer tablets containing hypromellose.
    Gohel M; Bariya SH
    Pharm Dev Technol; 2009; 14(6):650-8. PubMed ID: 19883254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcoating with Kollidon VA 64 as water barrier in a new combined native dextran/HPMC-cetyl alcohol controlled release tablet.
    Castellanos Gil E; Iraizoz Colarte A; Lara Sampedro JL; Bataille B
    Eur J Pharm Biopharm; 2008 May; 69(1):303-11. PubMed ID: 18053697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and evaluation of buccoadhesive propranolol hydrochloride tablet formulations: effect of fillers.
    Akbari J; Nokhodchi A; Farid D; Adrangui M; Siahi-Shadbad MR; Saeedi M
    Farmaco; 2004 Feb; 59(2):155-61. PubMed ID: 14871508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.